Abstract:Objective To study the effect of Niclosamide combined with low-dosage cisplatin on the proliferation, apoptosis, migration and invasion of human adrenocortical carcinoma SW-13 cell line and its potential mechanism. Methods SW-13 cells were cultured in vitro . CCK-8 method was used to detect the influence of Niclosamide and different concentrations of cisplatin on cell proliferation. There were four groups: a control group, a Niclosamide (1 μmol/L) group, a cisplatin (16 mg/L) group, and a combined Niclosamide (1 μmol/L) plus cisplatin (16 mg/L) group. The change of cell apoptosis was detected with Annexin V/PI staining flow cytometry and AO/EB staining method respectively. The changes of cell invasion and migration abilities were detected by Transwell assay and cell scratch assay. Western blot was used to detect the changes of expressions of Bcl-2, caspase-3, E-cadherin and vimentin. Results Niclosamide enhanced the inhibitory effect of cisplatin on proliferation of SW-13 cells (P < 0.05). The results of Annexin V/PI staining and AO/EB staining showed that the combined medicine group enhanced cell apoptosis rate more significantly than the Niclosamide group and the cisplatin group (P < 0.05). Transwell assay showed that compared with the Niclosamide and cisplatin groups, the combined medicine group decreased the invasion ability of SW-13 cells (P < 0.05), and cell scratch experiments showed that compared with the Niclosamide and cisplatin groups, the combined medicine group decreased the migration ability of SW-13 cells (P < 0.05). Western blot showed that compared with the Niclosamide and cisplatin groups, the combined medicine group more efficiently inhibited the expressions of Bcl-2 and vimentin (P < 0.05), promoted the expressions of caspase-3 and E-cadherin (P < 0.05). Conclusions Niclosamide can enhance the inhibitory effect of low-dosage cisplatin on the proliferation of SW-13 cells, promote cell apoptosis, and inhibit cell invasion and migration abilities. This is probably related to its influence on expressions of Bcl-2, caspase-3, E-cadherin and vimentin.